Copyright
©The Author(s) 2021.
World J Clin Cases. May 16, 2021; 9(14): 3356-3364
Published online May 16, 2021. doi: 10.12998/wjcc.v9.i14.3356
Published online May 16, 2021. doi: 10.12998/wjcc.v9.i14.3356
Study | Time to recurrence | Potential or definite cases | Antithrombotic or anticoagulant or antiplatelet medication | Outcome |
Marquardt et al[14], 2000 | 31 mo | Probable | None | Discharged without neurologic deficits |
Ildan et al[13], 2002 | Early rebleed | Possible | QReqse3 | Died after rebleed |
van der Worp et al[15], 2009 | 5 d | Possible | Antithrombotic for acute coronary syndrome | Died |
Reynolds et al[17], 2011 | 5 mo | Definite | Aspirin 81 mg for cardio- vascular protection, and discontinued after initial bleeding | Discharged with no neurologic deficits; complete resolution at 1 yr |
Rahme and Vyas[5], 2015 | 12 yr | Definite | None | Discharged |
Malhotra et al[16], 2016 | 8 yr | Definite | Aspirin 81 mg for myocardial infarction status post-angioplasty and stenting | Discharged Computed tomography angiography negative and no neurological deficits at 2-yr follow-up |
- Citation: Li J, Fang X, Yu FC, Du B. Recurrent perimesencephalic nonaneurysmal subarachnoid hemorrhage within a short period of time: A case report. World J Clin Cases 2021; 9(14): 3356-3364
- URL: https://www.wjgnet.com/2307-8960/full/v9/i14/3356.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v9.i14.3356